captopril has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flora, SJ; Mehta, A; Mishra, D; Pachauri, V; Saxena, G | 1 |
| Eid, BG; El-Shitany, NA | 1 |
2 other study(ies) available for captopril and cytochrome c-t
| Article | Year |
|---|---|
Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.
Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Biogenic Amines; Calcium; Captopril; Chelating Agents; Cytochromes c; Disease Models, Animal; DNA Damage; Drug Therapy, Combination; Exploratory Behavior; Lead Poisoning, Nervous System; Learning; Male; Membrane Potential, Mitochondrial; Memory; Mitochondria; Motor Activity; Nerve Degeneration; Neurons; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer | 2009 |
Captopril downregulates expression of Bax/cytochrome C/caspase-3 apoptotic pathway, reduces inflammation, and oxidative stress in cisplatin-induced acute hepatic injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Captopril; Caspase 3; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cisplatin; Cytochromes c; Down-Regulation; Humans; Liver Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction | 2021 |